Insider Trading History of Hirmand Mohammad

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Hirmand Mohammad since 2015. This trader's CIK number is 1654482. At the time of last reporting, Hirmand Mohammad was the EVP & Chief Medical Officer of Turning Point Therapeutics, Inc.. (stock ticker symbol TPTX). Also see all insider trading activities at Turning Point Therapeutics, Inc..

Note that in the past Hirmand Mohammad also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Turning Point Therapeutics, Inc. (TPTX) by Hirmand Mohammad

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 TPTX 0 $0 669 $24,284 0 $0
2021 TPTX 0 $0 10,300 $1,248,937 10,000 $547,299

Yearly summary of insider trading at Medivation, Inc. (MDVN) by Hirmand Mohammad

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 MDVN 0 $0 1,525 $62,685 17,560 $76,350
2015 MDVN 0 $0 1,307 $56,376 0 $0


Insider trading activities at 2 companies by Hirmand Mohammad:

1. Turning Point Therapeutics, Inc. (TPTX)

2. Medivation, Inc. (MDVN)

Table 1. Insider trading of Turning Point Therapeutics, Inc. (TPTX) by Hirmand Mohammad

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-02-09 TPTX Sale 669 36.30 24,284
2021-01-05 TPTX Sale 1,253 120.00 150,360
2021-01-04 TPTX Sale 9,047 121.43 1,098,577
2021-01-05 TPTX Option Ex 1,253 54.73 68,576
2021-01-04 TPTX Option Ex 8,747 54.73 478,723

Table 2. Insider trading of Medivation, Inc. (MDVN) by Hirmand Mohammad

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-09-15 MDVN Option Ex 17,560 4.35 76,350
2016-03-04 MDVN Sale 1,525 41.10 62,685
2015-12-03 MDVN Sale 1,075 43.40 46,655
2015-11-09 MDVN Sale 232 41.91 9,721

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hirmand Mohammad (EVP & Chief Medical Officer of Turning Point Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.